2001 Chronic Pain Patients 
Veriheal
MAY 18, 2023
Chronic pain —a condition that affects 50.2 annually — is one of the most common reasons why medical marijuana is sought out by patients in the United States, Canada, and beyond. Nonetheless, guidelines pertaining to the use of cannabis-based treatments for chronic pain relief have been somewhat hazy…up until now.
Veriheal
AUGUST 7, 2022
New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Puff Puff Post
DECEMBER 12, 2018
VANCOUVER — Doctors with opposing views on whether medical marijuana should be prescribed for various conditions agree on one thing: their profession is ill-prepared to deal with patients asking for a drug that lacks adequate clinical research. “So I think a lot of the claims are false.”
Cannabis Law Report
AUGUST 2, 2021
Study Results Indicate SCI-160 Has A Significant Analgesic Effect on Acute and Chronic Pain. ” A study conducted by The G4 Alliance reports 300 million surgical procedures are performed annually, with an estimated 60 to 70% of patients experiencing moderate to severe pain just after 24 hours of surgery.
Puff Puff Post
JUNE 5, 2019
It wasn’t until the movement by thousands of patients and patient advocates in the 1990’s that propelled the government to allow fair access to medical marijuana. Patients also had the right to produce their own or designate a grower to produce medical cannabis on their behalf. Consequences of Cannabis Use.
CannaTech
SEPTEMBER 16, 2018
Canada has been at the forefront of shaping much of the rhetoric surrounding cannabis since 2001. Doctors have remained integral parts of a patient’s cannabis journey through what is known as the Access to Cannabis for Medical Purposes Regulation (ACMPR) act. The Need for Cannabis Education Tailored to Patient and Doctor.
Dr. Michele Ross
DECEMBER 11, 2018
Approximately 10 million patients in the United States have fibromyalgia, and 75-90% are women. Patients with lupus, osteoarthritis, and or rheumatoid arthritis are at higher risk of developing fibromyalgia. No research has suggested harm from using cannabis in fibromyalgia patients.
Expert insights. Personalized for you.
98 
Let's personalize your content